
Dr Erik Lenguerrand
Expertise
Erik is a medical statistician and quantitative epidemiologist aiming to provide robust evidence that will inform best clinical practices. He has a particular interest in orthopaedic and obstetrics research.
Current positions
Associate Professor in Medical Statistics and Quantitative Epidemiology
Bristol Medical School (THS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Biography
Erik is an Associate Professor in Medical Statistics with expertise in quantitative epidemiology. He joined the University of Bristol in 2012 as a senior research associate, following positions as medical statistician at the Medical Rearch Council and French Institute of Science and Technology for Transport, Development and Networks( INRETS, UMRESTTE)
Projects and supervisions
Research projects
Evaluation of structured simulation-based training in operative vaginal birth
Role
Co-Investigator
Description
Stepped-wedge implementation and evaluation of simulation training on maternal and neonatal outcomes following operative vaginal birthManaging organisational unit
Bristol Medical School (THS)Dates
01/01/2017 to 01/04/2018
Thesis supervisions
Publications
Selected publications
01/09/2018Risk factors associated with revision for prosthetic joint infection after hip replacement
Lancet Infectious Diseases
Clinical and cost effectiveness of single stage compared with two stage revision for hip prosthetic joint infection (INFORM)
The BMJ
Temporal trends in stillbirth over eight decades in England and Wales
Journal of Global Health
Recent publications
12/03/2026Does the Tommy’s Pathway: Clinical Decision Support Tool have the potential to reduce disparities in UK maternity care? Findings from an early adopter implementation evaluation study
BMC Digital Health
How to optimise the use of innovative invasive devices
Pilot and Feasibility Studies
Social inequalities in patient outcomes after total hip replacement surgery for osteoarthritis in England
PLOS Medicine
Survivorship of modern total hip replacement to 30 years
The Lancet
Tommy’s Clinical Decision Support Tool
Pilot and Feasibility Studies




